Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada
Gong IY, Prica A, Ante Z, Calzavara A, Krzyzanowska MK, Singh S, Suleman A, Cheung MC, Crump M. Br J Haematol. 2023; Oct 27 [Epub ahead of print].
Publications
Machine learning–based early warning systems for acute care utilization during systemic therapy for cancer
Grant RC, He JC, Khan F, Liu N, Podolsky S, Kaliwal Y, Powis M, Notta F, Chan KKW, Ghassemi M, Gallinger S, Krzyzanowska MK. J Natl Compr Canc Netw. 2023; 21(10):1029–37.e21. Epub 2023 Oct 1.
Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice
Raphael J, Richard L, Lam M, Blanchette P, Leighl NB, Rodrigues G, Trudeau M, Krzyzanowska MK. J Natl Cancer Inst. 2023; May 17 [Epub ahead of print].
Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort study
Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Eskander A. CMAJ Open. 2023; 11(3):E426-33. Epub 2023 May 9.
Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: a population-based cohort study
Fu R, Sutradhar R, Li Q, Kalraj P, Dare A, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Louie AV, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Gomez D, Look Hong NJ, Tinmouth J, Eskander A. Cancer Med. 2023; 12(10):11849-59. Epub 2023 Mar 31.
Impact of antibiotic exposure before immune checkpoint inhibitor treatment on overall survival in older adults with cancer: a population-based study
Eng L, Sutradhar R, Niu Y, Liu N, iLiu Y, Kaliwal Y, Powis ML, Liu G, Peppercorn JM, Bedard PL, Krzyzanowska MK. J Clin Oncol. 2023; 41(17):JCO2200074. Epub 2023 Feb 24.
Timeliness and modality of treatment for new cancer diagnoses during the COVID-19 pandemic in Canada
Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Tinmouth J, Eskander A. JAMA Netw Open. 2023; 6(1):e2250394. Epub 2023 Jan 10.
Association of COVID-19 vaccination with breakthrough infections and complications in patients with cancer
Gong IY, Vijenthira A, Powis M, Calzavara A, Patrikar A, Sutradhar R, Hicks LK, Wilton D, Singh S, Krzyzanowska MK, Cheung MC. JAMA Oncol. 2023; 9(3):386-94. Epub 2022 Dec 29.
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer
Powis M, Sutradhar R, Patrikar A, Cheung M, Gong I, Vijenthira A, Hicks LK, Wilton D, Krzyzanowska MK, Singh S. J Natl Cancer Inst. 2023; 115(2):146-54. Epub 2022 Nov 2.
Incident cancer detection during multiple waves of COVID-19: the tsunami after the earthquake
Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Gomez D, McIsaac DI, Enepekides D, Urbach DR, Eskander A. J Natl Compr Canc Netw. 2022; 20(11):1190-92. Epub 2022 Nov 1.